145 related articles for article (PubMed ID: 2786431)
1. A kinetic study of erythrocyte-DNA/anti-DNA immune complex association and dissociation reactions in systemic lupus erythematosus.
Meryhew NL; Westling PR; Eerdmans ME; Janecek EJ; Runquist OA
Biochim Biophys Acta; 1989 Jun; 991(3):470-6. PubMed ID: 2786431
[TBL] [Abstract][Full Text] [Related]
2. Altered erythrocyte CR1 binding kinetics compensate for decreased binding capacity in rheumatoid arthritis.
Hargrove JK; Meryhew NL; Runquist OA
J Clin Chem Clin Biochem; 1990 Aug; 28(8):533-41. PubMed ID: 2147952
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analyses of the binding of soluble complement-fixing antibody/dsDNA immune complexes to CR1 on human red blood cells.
Edberg JC; Wright E; Taylor RP
J Immunol; 1987 Dec; 139(11):3739-47. PubMed ID: 2960742
[TBL] [Abstract][Full Text] [Related]
4. The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.
Horgan C; Burge J; Crawford L; Taylor RP
J Immunol; 1984 Oct; 133(4):2079-84. PubMed ID: 6332147
[TBL] [Abstract][Full Text] [Related]
5. A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1).
Ng YC; Peters DK; Cederholm-Williams SA; Walport MJ
Clin Exp Immunol; 1987 Jul; 69(1):89-97. PubMed ID: 3115654
[TBL] [Abstract][Full Text] [Related]
6. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
[TBL] [Abstract][Full Text] [Related]
7. Studies on the kinetics of binding of complement-fixing dsDNA/anti-dsDNA immune complexes to the red blood cells of normal individuals and patients with systemic lupus erythematosus.
Horgan C; Taylor RP
Arthritis Rheum; 1984 Mar; 27(3):320-9. PubMed ID: 6546694
[TBL] [Abstract][Full Text] [Related]
8. Complement fixation by small, DNase-resistant DNA-anti-DNA immune complexes.
Horgan C; Emlen W
Mol Immunol; 1987 Feb; 24(2):109-16. PubMed ID: 3497335
[TBL] [Abstract][Full Text] [Related]
9. The change in C3b receptors on erythrocytes from patients with systemic lupus erythematosus.
Yoshida K; Yukiyama Y; Hirose S; Miyamoto T
Clin Exp Immunol; 1985 Jun; 60(3):613-21. PubMed ID: 3160514
[TBL] [Abstract][Full Text] [Related]
10. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
11. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
Nielsen CH; Rasmussen JM; Voss A; Junker P; Leslie RG
Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
[TBL] [Abstract][Full Text] [Related]
12. Immune complex binding to erythrocyte-CR1 (CD 35), CR1 expression and levels of erythrocyte-fixed C3 fragments in SLE outpatients.
Jepsen HH; Møller Rasmussen J; Teisner B; Schrøder L; Holmskov U; Jarlbaek L; Isager H; Svehag SE
APMIS; 1990 Jul; 98(7):637-44. PubMed ID: 2144431
[TBL] [Abstract][Full Text] [Related]
13. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
Yen JH; Liu HW; Lin SF; Chen JR; Chen TP
J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes.
Emlen W; Carl V; Burdick G
Clin Exp Immunol; 1992 Jul; 89(1):8-17. PubMed ID: 1385769
[TBL] [Abstract][Full Text] [Related]
15. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes.
Taylor RP; Pocanic F; Reist C; Wright EL
Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):143-60. PubMed ID: 1833104
[TBL] [Abstract][Full Text] [Related]
16. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
Emlen W; Burdick G; Carl V; Lachmann PJ
J Immunol; 1989 Jun; 142(12):4366-71. PubMed ID: 2524529
[TBL] [Abstract][Full Text] [Related]
17. Immune complex clearance by complement receptor type 1 in SLE.
Kavai M
Autoimmun Rev; 2008 Dec; 8(2):160-4. PubMed ID: 18602499
[TBL] [Abstract][Full Text] [Related]
18. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
Schifferli JA; Ng YC; Paccaud JP; Walport MJ
Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
[TBL] [Abstract][Full Text] [Related]
19. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
[TBL] [Abstract][Full Text] [Related]
20. Association of leukocyte CR1 gene transcription with the disease severity and renal involvement in systemic lupus erythematosus.
Verma J; Arora V; Marwaha V; Kumar A; Das N
Lupus; 2005; 14(4):273-9. PubMed ID: 15864913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
